Ergosta-7,22-diene-2β,3α,9α-triol (EGDT) from Ganoderma lucidum inhibits nasopharyngeal carcinoma cells by blocking EGFR signaling pathway
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Chinese Herbal Medicines
- Vol. 10 (1) , 27-33
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Antidiabetic, Antihyperlipidemic and Antioxidant Activities of a Novel Proteoglycan from Ganoderma Lucidum Fruiting Bodies on db/db Mice and the Possible MechanismPLOS ONE, 2013
- Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro ModelsPLOS ONE, 2013
- Nasopharyngeal Carcinoma Signaling Pathway: An Update on Molecular BiomarkersInternational Journal of Cell Biology, 2012
- Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidumBioorganic & Medicinal Chemistry, 2011
- Triterpenes FromGanoderma LucidumInduce Autophagy in Colon Cancer Through the Inhibition of p38 Mitogen-Activated Kinase (p38 MAPK)Nutrition and Cancer, 2010
- Treatment approaches to nasopharyngeal carcinoma: a reviewAnti-Cancer Drugs, 2010
- Cytotoxic Activities of 9,11-Dehydroergosterol Peroxide and Ergosterol Peroxide from the Fermentation Mycelia of Ganoderma lucidum Cultivated in the Medium Containing Leguminous Plants on Hep 3B CellsJournal of Agricultural and Food Chemistry, 2009
- Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesisHead & Neck, 2008
- Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cellsBritish Journal of Pharmacology, 2007
- Ganoderma – A therapeutic fungal biofactoryPhytochemistry, 2006